Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW


Boehringer Ingelheim International GmbH has applied for the marketing of Pesorizumab Injection (trade name: Spevigo) for the treatment of acute attacks of generalized pustular psoriasis (GPP) in adults.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.